Abstract:Efficient and effective methods for converting human induced pluripotent stem cells into differentiated derivatives are critical for performing robust, large-scale studies of development and disease modelling, and for providing a source of cells for regenerative medicine. Here, we describe a 14-day neural differentiation protocol which allows for the scalable, simultaneous differentiation of multiple iPSC lines into cortical neural stem cells We currently employ this protocol to differentiate and compare sets of engineered iPSC lines carrying loss of function alleles in developmental disorder associated genes, alongside isogenic wildtype controls. Using RNA sequencing (RNA-Seq), we can examine the changes in gene expression brought about by each disease gene knockout, to determine its impact on neural development and explore mechanisms of disease. The 10-day Neural Induction period uses the well established dual-SMAD inhibition approach combined with Wnt/β-Catenin inhibition to selectively induce formation of cortical NSCs. This is followed by a 4-day Neural Maintenance period facilitating NSC expansion and rosette formation, and NSC cryopreservation. We also describe methods for thawing and passaging the cryopreserved NSCs, which are useful in confirming their viability for further culture. Routine implementation of immunocytochemistry Quality Control confirms the presence of PAX6-positive and/or FOXG1-positive NSCs and the absence of OCT4-positive iPSCs after differentiation. RNA-Seq, flow cytometry, immunocytochemistry (ICC) and RT-qPCR provide additional confirmation of robust presence of NSC markers in the differentiated cells. The broader utility and application of our protocol is demonstrated by the successful differentiation of wildtype iPSC lines from five additional independent donors. This paper thereby describes an efficient method for the production of large numbers of high purity cortical NSCs, which are widely applicable for downstream research into developmental mechanisms, further differentiation into postmitotic cortical neurons, or other applications such as large-scale drug screening experiments.

Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936

A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring

Generation and characterization of human-derived iPSC lines from two cousins with schizophrenia and bipolar disorder and their unaffected cousin

A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring

Establishment of an induced pluripotent cell line (ABCRIi001-A) from an elderly female for ageing research

Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia.

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Three induced pluripotent stem cell lines (TRNDi033-A, TRNDi034-A, TRNDi035-A) generated from lymphoblasts of three apparently healthy individuals

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

Establishment of SIAISi001-A, an induced pluripotent stem cell (iPSC) line from 66-year old mild cognitive impairment (MCI) with two copies of APOE4 gene.

Generation and benchmarking of a collection of hiPSC lines from Schizophrenia Patients with Diverse Clinical Profiles

Derivation of Ipsc Lines from Three Young Healthy Donors of Caucasian Origin (Nuigi035-A; NUIGi036-A; NUIGi037-A).

Generation of Induced Pluripotent Stem Cell Line (Ipti001-A) from a 62-Year Old Sporadic Alzheimer's Disease Patient with APOE3 (ε3/ε3) Genotype

Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors

Differentiation of human induced pluripotent stem cells into cortical neural stem cells

Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells from different genders

Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients

Generation of a Human-Derived Induced Pluripotent Stem Cell Line (Siaisi012-A) from an 82-Year-old Healthy Chinese Han Male.

Establishment of TUSMi003-A, an Induced Pluripotent Stem Cell (ipsc) Line from a 62-Year Old Chinese Han Patient with Alzheimer's Disease with ApoE3/4 Genetic Background

Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNFS621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming